vaccines
DomesticBiological Product
Recombinant Insulin Glargine Injection
甘李药业股份有限公司
Drug Information
| Generic name | 重组甘精胰岛素注射液 |
|---|---|
| Trade name | 长秀霖 |
| English name | Recombinant Insulin Glargine Injection |
| Dosage form | Injection |
| Specification | 3ml:300单位(预填充注射笔) |
| Category | Biological Product |
| Approval no. | 国药准字S20194001 |
| Drug code | 86900227000121 |
| Manufacturer | 甘李药业股份有限公司 |
| Production address | 北京市通州区漷县镇南凤西一路8号 |
| Origin | Domestic |
| Approval date | 2019-11-29 |
Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.